14.03.19|Lilach BaumerBased in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
09.01.19|Lilach BaumerThe company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter
04.07.18|CTechClal Biotechnology Industries is an Israel-based life sciences investment company
02.07.18|CTechThe company announced the issuance of 5.9 million new shares in April
23.04.18|CTechIsraeli satellite operator Spacecom bundled in a bid for Tel Aviv real estate. eBay Israel general manager Yuval Matalon steps down
23.04.18|Dror ReichThe company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange
23.01.18|CTechBioCanCell raises $25 million. Israel lags behind most developed countries on the Inclusive Development Index. Activist investor Jana Partners takes stake in Teva
23.01.18|Asaf ShalevThe company said it will use the funding for clinical trials of BC-819, a drug being designed to treat early stage bladder cancer
29.10.17|Lilach BaumerThe potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange